STOCK TITAN
  1. Home
  2. Sec-filings
  3. ANGO
  4. [Form 4] ANGIODYNAMICS INC Insider Trading Activity

AngioDynamics (ANGO) CFO withholds 12,067 shares to satisfy RSU tax obligations

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

AngioDynamics EVP and CFO Stephen A. Trowbridge reported tax-related share withholdings tied to restricted stock unit vesting. On July 16, 17 and 20, 2026, a total of 12,067 common shares were disposed of at $14.14, $13.51 and $13.71 per share, respectively, to satisfy tax withholding obligations on RSUs granted in 2025, 2024 and 2022. The filing indicates these exempt dispositions were not made under a Rule 10b5-1 trading plan.

Positive

  • None.

Negative

  • None.
Insider Trowbridge Stephen A
Role EVP and CFO
Type Security Shares Price Value
Tax Withholding Common Stock F3 717 $13.71 $10K
Tax Withholding Common Stock F2 3,510 $13.51 $47K
Tax Withholding Common Stock F1 7,840 $14.14 $111K
Holdings After Transaction: Common Stock — 244,562 shares (Direct)
Footnotes (3)
  1. F1. The exempt disposition of 7,840 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025.
  2. F2. The exempt disposition of 3,510 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024.
  3. F3. The exempt disposition of 717 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.
Shares withheld for taxes (07/16/2026) 7,840 shares Exempt disposition at $14.14 per share to satisfy tax withholding for RSUs granted July 16, 2025.
Shares withheld for taxes (07/17/2026) 3,510 shares Exempt disposition at $13.51 per share to satisfy tax withholding for RSUs granted July 17, 2024.
Shares withheld for taxes (07/20/2026) 717 shares Exempt disposition at $13.71 per share to satisfy tax withholding for RSUs granted July 20, 2022.
Total shares withheld for taxes 12,067 shares Aggregate shares disposed of in three code F transactions to satisfy tax withholding obligations.
restricted stock units financial
"pre-determined vesting of shares underlying restricted stock units granted to the reporting person"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"was made to satisfy tax withholding obligations in connection with the pre-determined vesting"
exempt disposition financial
"The exempt disposition of 7,840 shares of common stock of AngioDynamics, Inc."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transactions did AngioDynamics (ANGO) CFO Stephen Trowbridge report?
Stephen A. Trowbridge reported three exempt dispositions of AngioDynamics common stock. On July 16, 17 and 20, 2026, shares were withheld to cover tax obligations arising from pre-determined vesting of restricted stock units granted in 2025, 2024 and 2022.

How many AngioDynamics (ANGO) shares were withheld to cover the CFO’s taxes?
In total, 12,067 shares of AngioDynamics common stock were disposed of to satisfy tax withholding obligations. This includes 7,840 shares, 3,510 shares and 717 shares related to three separate restricted stock unit vesting events in July 2026.

At what prices were the AngioDynamics (ANGO) tax-withholding dispositions valued?
The exempt dispositions were valued at $14.14, $13.51 and $13.71 per share. Each price corresponds to a separate transaction on July 16, 17 and 20, 2026, when shares were withheld to cover taxes on vesting restricted stock units.

Were the AngioDynamics (ANGO) insider transactions made under a Rule 10b5-1 plan?
No. The filing’s Rule 10b5-1 checkbox is not selected, and the footnotes describe the transactions as exempt dispositions for tax withholding. This indicates the reported share withholdings were not executed under a pre-arranged Rule 10b5-1 trading plan.

Which equity awards triggered the AngioDynamics (ANGO) CFO’s tax-withholding share dispositions?
The dispositions relate to restricted stock units granted on July 16, 2025; July 17, 2024; and July 20, 2022. Shares were withheld upon the pre-determined vesting of these RSUs to satisfy associated tax withholding obligations for Stephen A. Trowbridge.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Trowbridge Stephen A
(Last)(First)(Middle)
14 PLAZA DRIVE
(Street)
LATHAM NEW YORK 12110
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
ANGIODYNAMICS INC [ ANGO ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP and CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/16/2026F7,840(1)D$14.14248,789D
Common Stock07/17/2026F3,510(2)D$13.51245,279D
Common Stock07/20/2026F717(3)D$13.71244,562D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The exempt disposition of 7,840 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025.
2. The exempt disposition of 3,510 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024.
3. The exempt disposition of 717 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.
/s/ Lawrence T. Weiss, as Attorney in Fact07/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR